Clinical Trial Update: Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the imaging agent [F-18]Flornaptitril-PET to predict clinical progression in individuals with mild cognitive impairment and su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Traumatic Encephalopathy

Drugs mentioned

• [F-18]Flornaptitril-PET (Flornaptitril PET radiotracer (F-18))

Snippet

Sponsor: CereMark Pharma, LLC | Conditions: Alzheimer Disease, Chronic Traumatic Encephalopathy | Phase 3 | Status: RECRUITING